SearchDictionaryMobileLogin

Vasorelaxing effect of the Rho-kinase inhibitor, Y-27632, in isolated canine basilar arteries.

AbstractOBJECTIVES: Increased calcium sensitization mediated by Rho/Rho-kinase may be important in the pathogenesis of cerebral vasospasm. The effects of a highly selective Rho-kinase inhibitor, Y-27632, were investigated on spasmogen-induced contractions of canine basilar artery. METHODS: Typical spasmogenic substances present after subarachnoid hemorrhage (SAH), including prostaglandin F2a (PGF2a), 12-deoxyphorbol 13-isobutyrate (DPB), sphingosylpho-sphorylcholine (SPC) and high K+, were used in the study. Isometric tension was recorded in canine basilar artery rings in vitro. Intracellular calcium concentration ([Ca2+]i) and contraction force were measured simultaneously in fura-2-loaded canine basilar artery strips. The myosin light chain (MLC) phosphorylation levels were measured by glycerol gel electrophoresis followed by Western blotting. RESULTS: Isometric tension recording revealed that the Rho-kinase inhibitor, Y-27632, dose-dependently inhibited vasocontraction induced by PGF2a and SPC, but not that induced by DPB. Simultaneous recordings of [Ca2+]i and tension revealed that the vasorelaxing effect of Y-27632 was not associated with changes in [Ca2+]i, suggesting that Y-27632 may inhibit calcium sensitization. Vasocontraction induced by DPB was not inhibited by Y-27632, but was inhibited by staurosporine. Phosphorylation of MLC was increased by PGF2a and SPC, and significantly inhibited by Y-27632, whereas such phosphorylation was increased by DPB, but not significantly inhibited by Y-27632. DISCUSSION: Several spasmogenic mediators released after SAH may cause vasospasm through Rho-kinase-mediated increase in calcium sensitization. Rho-kinase inhibitors, including Y-27632, may be effective for the prevention of cerebral vasospasm after SAH.
AuthorsYasuhiro Hashiba, Masahiko Tosaka, Nobuhito Saito, Hideaki Imai, Tatsuya Shimizu, Tomio Sasaki (Affiliation: Department of Neurosurgery, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan. nshashi at showa.gunma-u.ac.jp)
JournalNeurological research (Neurol Res) Vol. 29 Issue 5 Pg. 485-9 (Jul 2007) ISSN: 0161-6412 England
PMID17806208 (Publication Type: In Vitro, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amides
  • Enzyme Inhibitors
  • Myosin Light Chains
  • Pyridines
  • sphingosine phosphorylcholine
  • Phosphorylcholine
  • Sphingosine
  • Y 27632
  • Dinoprost
  • Calcium
Topics
  • Amides (pharmacology)
  • Animals
  • Basilar Artery (drug effects)
  • Calcium (metabolism)
  • Dinoprost (pharmacology)
  • Dogs
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors (pharmacology)
  • Myosin Light Chains (metabolism)
  • Phosphorylation (drug effects)
  • Phosphorylcholine (analogs & derivatives, pharmacology)
  • Pyridines (pharmacology)
  • Sphingosine (analogs & derivatives, pharmacology)
  • Vasodilation (drug effects)